Practical Guidance on Optimizing CLL Care in the Era of Molecular Therapies

This comprehensive program gathers CLL management insights from our distinguished CLL experts and features education on emerging and established treatment strategies enhanced by a decision support tool for individualizing these treatments to your patients. All aspects of this program are designed to complement each other, including the interactive treatment decision tool, expert commentaries, and an expert-authored module with downloadable slideset.
Emily Bucholtz Headshot
Emily Bucholtz, RPh
Nichole Fisher Headshot
Nichole Fisher, RN, BSN
Jeff P. Sharman, MD

Downloadable Slideset

Download these slides to review the most recent clinical data on new agents in both frontline and relapsed/refractory CLL.

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: July 17, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
CLL Society Logo
Supported by educational grants from
AbbVie
AstraZeneca
Pharmacyclics LLC, An AbbVie Company
Verastem Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue